News
Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they received 10 weeks ago that laid them off. Damage to their projects may ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
A doctor and HIV expert reinstated at the CDC this week said the late termination of the surveys would waste millions of taxpayer dollars that have already been spent on data collection. Two large ...
Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...
A protest at the Centers for Disease Control and Prevention over budget cuts tipped over into calls for Health and Human Services Secretary Robert F. Kennedy Jr. to resign.
Treatment rates were far higher for those over 50. As a result, health officials doubled down on outreach to younger generations.
A June stu d y estimated as many as 2.2 million Americans could benefit from HIV prevention medications. Men account for nearly 80% of new cases, mostly involving gay or bisexual men, the CDC said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results